Company Filing History:
Years Active: 2018
Title: Milu Cherian: Innovator in Oncological Research
Introduction
Milu Cherian is a notable inventor based in Memphis, TN (US). She has made significant contributions to the field of oncological research through her innovative work. Her research focuses on developing selective inhibitors that target specific receptors involved in cell proliferation.
Latest Patents
Milu Cherian holds 1 patent for her invention titled "Selective inhibitors of constitutive androstane receptor." This patent describes compounds that act as antagonists of the constitutive androstane receptor (CAR), demonstrating specificity for CAR over other proteins, including PXR. The disclosed compounds are particularly useful in treating or controlling cell proliferative disorders, especially oncological disorders such as cancer. The abstract of her patent serves as a scanning tool for searching within the relevant field and is not intended to limit the scope of the invention.
Career Highlights
Milu Cherian is currently affiliated with St. Jude Children's Research Hospital, where she continues her impactful research. Her work is instrumental in advancing the understanding and treatment of cancer, contributing to the hospital's mission of improving pediatric healthcare.
Collaborations
Milu collaborates with esteemed colleagues, including Taosheng Chen and Wenwei Lin, who share her commitment to innovative research in the field of oncology.
Conclusion
Milu Cherian's contributions to oncological research through her patent and work at St. Jude Children's Research Hospital highlight her dedication to improving cancer treatment. Her innovative approach continues to inspire advancements in medical science.